Prolactin monitoring in schizophrenia should be indicated by symptomatology not time
Authors:
- 6 September 2017
- journal article
- other
- Published by SAGE Publications in Australian & New Zealand Journal of Psychiatry
- Vol. 51 (11) , 1152-1153
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the management of schizophrenia and related disordersAustralian & New Zealand Journal of Psychiatry, 2016
- Relationship between prolactin, breast cancer risk, and antipsychotics in patients with schizophrenia: a critical reviewActa Psychiatrica Scandinavica, 2015
- Psychotropic-Induced Hyperprolactinemia: A Clinical ReviewPsychosomatics, 2014
- Cortical Stimulation of the Prefrontal Cortex With Transcranial Direct Current Stimulation Reduces Cue-Provoked Smoking CravingThe Journal of Clinical Psychiatry, 2008
- Elevated prolactin levels in patients with schizophrenia: mechanisms and related adverse effectsPsychoneuroendocrinology, 2003